Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2020-11-27 13:41 Tx date 2020-11-26 |
$ASP
Acerus Pharmaceuticals Corporation |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: First Generation Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$12,734,214
+509,368,574 vol $0.025 each |
1,376,502,750 | |
Filed 2020-04-02 17:33 Tx date 2020-03-30 |
$ASP
Acerus Pharmaceuticals Corporation |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$104,645
+2,315,172 vol $0.0452 each |
2,940,172 | |
Filed 2020-02-21 17:04 Tx date 2020-02-21 |
$ASP
Acerus Pharmaceuticals Corporation |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: First Generation Capital Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+749,230,776 vol |
867,134,176 | |
Filed 2019-12-12 10:24 Tx date 2019-03-10 |
$ASP
Acerus Pharmaceuticals Corporation |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-25,000 vol |
625,000 | |
Filed 2019-12-12 10:22 Tx date 2018-11-06 |
$ASP
Acerus Pharmaceuticals Corporation |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-25,000 vol |
450,000 | |
Filed 2019-03-29 Tx date 2019-03-29 |
$ASP
Acerus Pharmaceuticals Corporation |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: First Generation Capital Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$3,000,000
+15,384,616 vol $0.195 each |
117,903,400 | |
Filed 2019-03-07 Tx date 2019-03-06 |
$ASP
Acerus Pharmaceuticals Corporation |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$26,000
+200,000 vol $0.13 each |
675,000 | |
Filed 2018-03-26 Tx date 2018-03-23 |
$ASP
Acerus Pharmaceuticals Corporation |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
475,000 | |
Filed 2017-03-13 Tx date 2017-03-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
375,000 | |
Filed 2016-05-18 Tx date 2016-05-13 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: First Generation Capital Inc. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,246,388
+51,437,691 vol $0.1992 each |
102,518,784 | |
Filed 2016-03-31 Tx date 2016-03-28 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: First Generation Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,400
+74,000 vol $0.10 each |
51,081,093 | |
Filed 2016-03-31 Tx date 2016-03-28 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: First Generation Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$368,000
+2,944,000 vol $0.125 each |
51,007,093 | |
Filed 2016-03-28 Tx date 2016-03-24 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: First Generation Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,840
+272,000 vol $0.095 each |
48,063,093 | |
Filed 2016-03-28 Tx date 2016-03-23 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: First Generation Capital Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,010
+189,000 vol $0.09 each |
47,791,093 | |
Filed 2016-03-08 Tx date 2016-03-04 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Ihnatowycz, Ian Orest
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
175,000 |